Please use this identifier to cite or link to this item:
Title: Mutational spectrum of Duchenne muscular dystrophy in Spain: Study of 284 cases.
Other Titles: Espectro mutacional de la distrofia muscular de Duchenne en España: estudio de 284 casos.
Authors: Vieitez, I
Gallano, P
González-Quereda, L
Borrego, S
Marcos, I
Millán, J M
Jairo, T
Prior, C
Molano, J
Trujillo-Tiebas, M J
Gallego-Merlo, J
García-Barcina, M
Fenollar, M
Navarro, C
Keywords: Análisis mutacional;Diagnóstico genético;Distrofia muscular Duchenne;Duchenne muscular dystrophy;Genetic diagnosis;Multiplex ligation-dependent probe amplification;Mutational analysis;Secuenciación;Sequencing
metadata.dc.subject.mesh: Adult
DNA Mutational Analysis
Gene Deletion
Muscular Dystrophy, Duchenne
Issue Date: 9-Mar-2016
Abstract: Duchenne muscular dystrophy (DMD) is a severe X-linked recessive neuromuscular disease that affects one in 3500 live-born males. The total absence of dystrophin observed in DMD patients is generally caused by mutations that disrupt the reading frame of the DMD gene, and about 80% of cases harbour deletions or duplications of one or more exons. We reviewed 284 cases of males with a genetic diagnosis of DMD between 2007 and 2014. These patients were selected from 8 Spanish reference hospitals representing most areas of Spain. Multiplex PCR, MLPA, and sequencing were performed to identify mutations. Most of these DMD patients present large deletions (46.1%) or large duplications (19.7%) in the dystrophin gene. The remaining 34.2% correspond to point mutations, and half of these correspond to nonsense mutations. In this study we identified 23 new mutations in DMD: 7 large deletions and 16 point mutations. The algorithm for genetic diagnosis applied by the participating centres is the most appropriate for genotyping patients with DMD. The genetic specificity of different therapies currently being developed emphasises the importance of identifying the mutation appearing in each patient; 38.7% of the cases in this series are eligible to participate in current clinical trials.
metadata.dc.identifier.doi: 10.1016/j.nrl.2015.12.009
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons